Continuing its policy of expansion and growth, last March BIOIBERICA, inaugurated its new facilities in the United States

Bioibérica-Nebraska Inc. Is an enterprise born out of the great demand of glycosaminoglycanes coming from the US market. These facilities will be mostly dedicated to the production of Chondroitin Sulfate for the American market, in which BIOIBERICA has a position of leadership.

The facilities purchased are located in Geneva, Nebraska, and they have a total surface area of 40 acres, including two buildings with a total surface of 17556 m². If BIOIBERICA is currently the largest producer worldwide of glycosaminoglycanes, this new purchase will consolidate its leading position.

With this great investment carried out in Nebraska, we intend to utilize the most modern glycosaminoglycanes extraction technology which our R+D department has optimized by years of extensive work.